Questions around a case of in utero thrombosis in a premature child, concerning the management of anticoagulant treatments
- PMID: 37775260
- DOI: 10.1136/ejhpharm-2023-003826
Questions around a case of in utero thrombosis in a premature child, concerning the management of anticoagulant treatments
Abstract
We report the case of a preterm infant presenting a thrombosis, discovered on ultrasound at 22 weeks of gestational age and confirmed at birth following additional examinations. We describe the anticoagulant treatment of this patient by intravenous enoxaparin, tinzaparin and rivaroxaban, from questioning to practice.
Keywords: Administration, Intravenous; Anticoagulants; Case Reports; Drug Monitoring; NEONATOLOGY; PEDIATRICS; Thromboembolism.
© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: S P-L is an associate editor for EJHP.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical